oxidopamine has been researched along with Neuritis in 2 studies
Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).
Neuritis: A general term indicating inflammation of a peripheral or cranial nerve. Clinical manifestation may include PAIN; PARESTHESIAS; PARESIS; or HYPESTHESIA.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Koprich, JB | 1 |
Reske-Nielsen, C | 1 |
Mithal, P | 1 |
Isacson, O | 1 |
Donnerer, J | 1 |
2 other studies available for oxidopamine and Neuritis
Article | Year |
---|---|
Neuroinflammation mediated by IL-1beta increases susceptibility of dopamine neurons to degeneration in an animal model of Parkinson's disease.
Topics: Animals; Antirheumatic Agents; Disease Models, Animal; Disease Susceptibility; Dopamine; Female; Int | 2008 |
Improved neurochemical recovery of 6-hydroxydopamine-lesioned postganglionic sympathetic neurons by nerve growth factor in the adult rat.
Topics: Age Factors; Animals; Capsaicin; Freund's Adjuvant; Male; Microinjections; Nerve Growth Factors; Ner | 1996 |